Can Ear Stimulation Help Difficult-to-Control Blood Pressure?

Key Takeaways

• A small clinical trial tested a home-use device that delivers mild electrical stimulation through clips placed on the outer ear.

• All 63 participants had uncontrolled high blood pressure despite taking at least one blood-pressure medication.

• The device appeared safe, tolerable, and feasible for participants to use at home.

• Across the full study group, active stimulation did not lower blood pressure significantly more than a sham device.

• A planned analysis suggested larger blood-pressure reductions among participants with more severe blood pressure issues, but this finding needs confirmation in larger trials.

A Noninvasive Idea

The approach, called transcutaneous autonomic neuromodulation, aims to influence the autonomic nervous system—the network that helps regulate functions such as heart rate and blood pressure. Participants used a handheld device with clips on the tragus, the small cartilage flap in front of the ear canal.

The appeal is practical: it does not require surgery, clinic-based treatment, or a new medication. But an appealing mechanism is not the same as a proven treatment.

What the Trial Found

Participants were randomly assigned to active stimulation or a sham device. They used the device for 30 minutes daily during the first two weeks, then once weekly for another 10 weeks.

The primary result was negative: blood-pressure changes did not differ significantly between the active and sham groups overall. That result should remain the main takeaway.

A Signal Worth Testing

People who began the study with more severe blood pressure issues appeared to benefit more from active stimulation in a prespecified subgroup analysis. Because this was a small trial, that observation is a research lead—not proof that the device works for severe blood pressure issues.

Larger trials will need to confirm the finding, identify which patients might benefit, and show whether any blood-pressure reduction is durable and clinically meaningful.

What It Means for Longevity

This is not a replacement for prescribed blood pressure issues care. For now, the device is best viewed as an early-stage, noninvasive strategy that was feasible and well tolerated but did not demonstrate a significant overall benefit in this trial.

References:

Gupta A, et al. Safety, Acceptability and Efficacy of Noninvasive Transcutaneous-Autonomic Neuromodulation in Uncontrolled Hypert. Hypert (2026)